Kathryn Guarini
Director, Regeneron Pharmaceuticals.
Companies
- Regeneron PharmaceuticalsBoard member Sep 12, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Regeneron Pharmaceuticals REGN603 shares2$476.7K at $790.61Sep 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 2, 2026Sold 400 shares at $850.00 of Regeneron Pharmaceuticals2
- Sep 2, 2026Exercised options 400 shares at $719.37 of Regeneron Pharmaceuticals2
- Aug 10, 2026Sold 400 shares at $800.00 of Regeneron Pharmaceuticals3
- Aug 10, 2026Exercised options 400 shares at $719.37 of Regeneron Pharmaceuticals3
- Jan 2, 2026Granted 155 shares of Regeneron Pharmaceuticals4
- Jan 2, 2025Granted 166 shares of Regeneron Pharmaceuticals5
- Jan 2, 2024Granted 42 shares of Regeneron Pharmaceuticals6
- Sep 8, 2023Granted 240 shares of Regeneron Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Aug 12, 2026
- 4SEC EDGARForm 4 filed Jan 6, 2026
- 5SEC EDGARForm 4 filed Jan 6, 2025
- 6SEC EDGARForm 4 filed Jan 4, 2024
- 7SEC EDGARForm 4 filed Sep 12, 2023